Advertisement
Advertisement
U.S. markets open in 1 hour 24 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9100+0.2800 (+7.71%)
At close: 04:00PM EDT
3.9500 +0.04 (+1.02%)
Pre-Market: 07:00AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.6300
Open3.5000
Bid0.0000 x 1200
Ask3.9600 x 3000
Day's Range3.5000 - 3.9800
52 Week Range0.4600 - 4.0900
Volume287,676
Avg. Volume1,449,100
Market Cap151.261M
Beta (5Y Monthly)0.21
PE Ratio (TTM)N/A
EPS (TTM)-1.2810
Earnings DateAug 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TRVI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Trevi Therapeutics, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
Advertisement
Advertisement